264 related articles for article (PubMed ID: 19709217)
1. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases.
Loubinoux J; Bronowicki JP; Pereira IA; Mougenel JL; Faou AE
FEMS Microbiol Ecol; 2002 May; 40(2):107-12. PubMed ID: 19709217
[TBL] [Abstract][Full Text] [Related]
2. Isolation of sulfate-reducing bacteria from human thoracoabdominal pus.
Loubinoux J; Jaulhac B; Piemont Y; Monteil H; Le Faou AE
J Clin Microbiol; 2003 Mar; 41(3):1304-6. PubMed ID: 12624073
[TBL] [Abstract][Full Text] [Related]
3. Isolation and evaluation of susceptibility to sulphasalazine of Desulfovibrio desulfuricans strains from the human digestive tract.
Dzierzewicz Z; Cwalina B; Gawlik B; Wilczok T; Gonciarz Z
Acta Microbiol Pol; 1997; 46(2):175-87. PubMed ID: 9429289
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Desulfovibrio desulfuricans intestinal strains to sulfasalazine and its biotransformation products.
Dzierzewicz Z; Cwalina B; Weglarz L; Wiśniowska B; Szczerba J
Med Sci Monit; 2004 Jun; 10(6):BR185-90. PubMed ID: 15173665
[TBL] [Abstract][Full Text] [Related]
5. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer.
Balamurugan R; Rajendiran E; George S; Samuel GV; Ramakrishna BS
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1298-303. PubMed ID: 18624900
[TBL] [Abstract][Full Text] [Related]
6. Diversity and Comparison of Intestinal
Lu G; Zhang Y; Ren Y; Shi JS; Xu ZH; Geng Y
Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838242
[No Abstract] [Full Text] [Related]
7. Hydrogen metabolism in Desulfovibrio desulfuricans strain New Jersey (NCIMB 8313)--comparative study with D. vulgaris and D. gigas species.
Carepo M; Baptista JF; Pamplona A; Fauque G; Moura JJ; Reis MA
Anaerobe; 2002 Dec; 8(6):325-32. PubMed ID: 16887677
[TBL] [Abstract][Full Text] [Related]
8. Kinetic Properties of Pyruvate Ferredoxin Oxidoreductase of Intestinal Sulfate-Reducing Bacteria Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9.
Kushkevych IV
Pol J Microbiol; 2015; 64(2):107-14. PubMed ID: 26373169
[TBL] [Abstract][Full Text] [Related]
9. Lactate has the potential to promote hydrogen sulphide formation in the human colon.
Marquet P; Duncan SH; Chassard C; Bernalier-Donadille A; Flint HJ
FEMS Microbiol Lett; 2009 Oct; 299(2):128-34. PubMed ID: 19732152
[TBL] [Abstract][Full Text] [Related]
10. Metabolic niche of a prominent sulfate-reducing human gut bacterium.
Rey FE; Gonzalez MD; Cheng J; Wu M; Ahern PP; Gordon JI
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13582-7. PubMed ID: 23898195
[TBL] [Abstract][Full Text] [Related]
11. Biotechnological potential of sulfate-reducing bacteria for transformation of nitrocellulose.
Petrova OE; Tarasova NB; Davydova MN
Anaerobe; 2002 Dec; 8(6):315-7. PubMed ID: 16887675
[TBL] [Abstract][Full Text] [Related]
12. Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera.
Warren YA; Citron DM; Merriam CV; Goldstein EJ
J Clin Microbiol; 2005 Aug; 43(8):4041-5. PubMed ID: 16081948
[TBL] [Abstract][Full Text] [Related]
13. Model-based Characterization of the Parameters of Dissimilatory Sulfate Reduction Under the Effect of Different Initial Density of Desulfovibrio piger Vib-7 Bacterial Cells.
Kushkevych I; Bolis M; Bartos M
Open Microbiol J; 2015; 9():55-69. PubMed ID: 26668663
[TBL] [Abstract][Full Text] [Related]
14. Activity of selected salicylamides against intestinal sulfate-reducing bacteria.
Kushkevych I; Kollar P; Suchy P; Parak T; Pauk K; Imramovsky A
Neuro Endocrinol Lett; 2015; 36 Suppl 1():106-13. PubMed ID: 26757109
[TBL] [Abstract][Full Text] [Related]
15. Acetate kinase Activity and Kinetic Properties of the Enzyme in Desulfovibrio piger Vib-7 and Desulfomicrobium sp. Rod-9 Intestinal Bacterial Strains.
Kushkevych IV
Open Microbiol J; 2014; 8():138-43. PubMed ID: 25598851
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Physiological Parameters of
Kushkevych I; Dordević D; Kollár P
Open Life Sci; 2018 Jan; 13():481-488. PubMed ID: 33817117
[TBL] [Abstract][Full Text] [Related]
17. Differences between Desulfovibrio desulfuricans intestinal strains with respect to their ability of sulphasalazine biotransformation.
Dzierzewicz Z; Cwalina B; Kuśmierz D; Kwapisz I
Acta Pol Pharm; 2000 Nov; 57 Suppl():124-6. PubMed ID: 11293241
[TBL] [Abstract][Full Text] [Related]
18. Analysis of pH Dose-dependent Growth of Sulfate-reducing Bacteria.
Kushkevych I; Dordević D; Vítězová M
Open Med (Wars); 2019; 14():66-74. PubMed ID: 30775453
[TBL] [Abstract][Full Text] [Related]
19. NADH and NADPH peroxidases as antioxidant defense mechanisms in intestinal sulfate-reducing bacteria.
Kushkevych I; Dordević D; Alberfkani MI; Gajdács M; Ostorházi E; Vítězová M; Rittmann SKR
Sci Rep; 2023 Aug; 13(1):13922. PubMed ID: 37626119
[TBL] [Abstract][Full Text] [Related]
20. Biocorrosive behavior of sulphate-reducing bacteria in kerr endodontic files: Determination of the corrosion.
Heggendorn FL; Teixeira Pinto LAL; Gonçalves LS; Lione VOF; Cravo Junior WB; Soares Lutterbach MT
J Conserv Dent; 2020; 23(2):196-200. PubMed ID: 33384495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
